Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 234

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 234
---
 as to permit the Meeting to be held as soon as reasonably practicable.                                    |

| (b) | As promptly as reasonably practicable after the expiry or termination of the SEC Clearance Period, the Company                                                                                                                                    
 shall mail to each Shareholder and such other third parties as may be required pursuant to the Interim Order and applicable Laws, the Circular and all other proxy materials for the Meeting, and if necessary in order to comply with applicable 
 Securities Laws, after the Circular shall have been so mailed, promptly circulate amended, supplemental or supplemented proxy material, and, if required in connection therewith, re-solicit proxies. The Company                                 
 shall cause the Circular to be mailed in all jurisdictions where the same is required to be mailed.                                                                                                                                               |

| (c) | The Company shall ensure that the Circular complies in material respects with the Interim Order and Law, does                                                                                                                                     
 not contain any Misrepresentation (other than in respect to any written information with respect to the Purchaser that is furnished in writing by or on behalf of the Purchaser for inclusion in the Circular) and provides the Shareholders with 
 sufficient information to permit them to form a reasoned judgement concerning the matters to be placed before the Meeting.                                                                                                                        |

| (d) | Without limiting the generality of Section 2.4(a), the Circular must include: (i) a summary and a                                                                                                                                                
 copy of the Fairness Opinion, (ii) a statement that the Transaction Committee has received the Fairness Opinion and has, after receiving advice from its financial advisers and outside legal counsel, unanimously recommended that the Board    
 approve the Arrangement, (iii) a statement that the Board has received the Fairness Opinion and has, after receiving advice from its financial advisers and outside legal counsel and the unanimous recommendation of the Transaction Committee, 
 unanimously determined that the Arrangement Resolution is in the best interests of the Company and is fair to the Shareholders and that the Board unanimously recommends that the Shareholders vote in favour of the Arrangement Resolution (the 
 “Board Recommendation”), and (iv) a statement that each director and officer of the Company has entered into a Voting and Support Agreement pursuant to which such director or officer has agreed to vote all of his or her                      
 securities in favour of the Arrangement Resolution.                                                                                                                                                                                              |

| (e) | The Company shall give the Purchaser and its outside legal counsel a reasonable opportunity to review and 
 comment on drafts of the Circular and other related documents, and shall give reasonable                  |

A-21

| consideration